SCHEMBL3561489

SCHEMBL3561489

CC(=O)n1cc(OCCN(C)C)c2cc(Cl)cc(Br)c21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
MAPT P10636 1/20 0.40
HTR7 P34969 1/20 0.38
LMNA P02545 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
ATR Q13535 1/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
CYP1A2 P05177 1/20 0.35
ADRA2A P08913 1/20 0.35
CYP2D6 P10635 1/20 0.35
PKM P14618 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
ADRA1D P25100 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3560720 0.88 MAPT (0.41) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL3555783 0.88 HTR7 (0.40) KDM4EALDH1A1SMN1; SMN2HTR7LMNA
SCHEMBL6820963 0.85 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL6820288 0.84 HTR7 (0.43) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL3565222 0.79 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL6823917 0.77 HTR7 (0.43) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL14953563 0.77 KDM4E (0.42) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL3562648 0.76 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL6817280 0.75 HTR7 (0.45) KDM4EALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL3555445 0.75 HTR6 (0.48) KDM4EALDH1A1SMN1; SMN2GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT KDM4E 3751/4885ALDH1A1 1943/4885SMN1; SMN2 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.